Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC naming Duncan Smith .
Filed returns
6
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2024 | Janssen Sciences Ireland UC | Health | Briefing for Opposition spokesperson on life sciences industry priorities. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government & Oireachtas members re new medicines funding. (Matters involving public funds) | 7 | On lobbying.ie |
| Jan–Apr 2024 | Janssen Sciences Ireland UC | Health | Engagement with Duncan Smith TD on medicines access for Irish patients (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Oireachtas members on the need for new development funding for new medicines reimbursements in 2024 (Matters involving public funds) | 24 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 4 | 66.7% | |
| Budgetary matters | 2 | 33.3% |